Health Innovation Roundup

The Health Innovation Roundup provides you with the latest headlines and happenings related to health innovation in the Edmonton region.
Sponsored by:
Health Cities

Written by:
Hiba Kamal-Choufi

Hiba Kamal-Choufi

Published every Wednesday

Get it free:



Recent editions

Wednesday, January 19, 2022

The latest headlines & happenings in health innovation in Edmonton. AltaML has formed a strategic alliance with Amplitude Venture Capital, a top Canadian firm focused on life sciences and building precision medicine companies. The partnership will look to leverage the possibility of artificial intelligence and machine learning in the biotechnology sector.

Read this edition

Wednesday, January 12, 2022

The latest headlines & happenings in health innovation in Edmonton. Edmonton-based Entos Pharmaceuticals has signed an agreement with Eli Lilly, giving the American pharmaceutical company exclusive rights to Entos's Fusogenix PLV technology for $50 million now and up to $400 million in the future.

Read this edition

Wednesday, January 5, 2022

The latest headlines & happenings in health innovation in Edmonton. Health innovators and entrepreneurs across Alberta have two more weeks to apply for the inaugural Startup TNT Life Sciences Investment Summit in March. Startup TNT has partnered with Applied Pharmaceutical Innovation (API) to organize the event, which will be the province's largest investment summit focused on life sciences — with a goal of investing over $1 million into participating seed-stage companies.

Read this edition

Recent articles

Three vials of vaccine

A look at health innovation in Edmonton during 2021

As Alberta's health innovation industry grows, Edmonton companies continue to demonstrate their ability to be leaders in areas like drug and vaccine development and biotechnology infrastructure.

Continue reading
Dr. John Lewis stands at a podium

Entos Pharmaceuticals secures partial funding for commercial manufacturing facility in Edmonton

The provincial government has committed $15.5 million in funding to Entos Pharmaceuticals to establish a new commercial manufacturing facility in Edmonton, which would produce vaccines as well as future genetic medicines. Now it's "a dance" to secure the rest of the funding needed.

Continue reading
A small, plastic sensor tucked behind a woman's ear

AltaML and PROTXX make headway on concussion diagnostics

A partnership between precision health-care technology company PROTXX and Edmonton-based AltaML has resulted in a new benchmark in concussion diagnostics, the results of which were recently published in the journal Sensors.

Continue reading


Thank to you to our Cultivator sponsors for helping to make our work possible:

University Hospital Foundation Boehringer Ingelheim DynaLIFE Applied Pharmaceutical Innovation University Health Accelerator DrugBank Alberta Innovates Edmonton Global

Sponsor the Health Innovation Roundup